DUCAT VENTURES |
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| Mar. 25 | OptiBiotix Health raises GBP1.4 million to invest in "driving sales" | AN |
| Mar. 25 | OptiBiotix Health Raises GBP1.4 Million via Share Placing, Subscription | MT |
Chart calendar DUCAT VENTURES
84c2efc0d6e307cc55a9806143091577.334jUmjp_z4PdIuG_yKy0ARA1UCb7mZn1bxgBFriytE.5iRZYAyrkEhLGdzqs0PWpGJ34W3zjF9enooJMW6Psom5TmIqI7qSRngz0g~6c85d203309db6175469a2de846d9d25
Upcoming events on DUCAT VENTURES
Past events on DUCAT VENTURES
| 2023-09-27 02:00 am | Q2 2023 Earnings Release |
| 2023-07-26 06:00 am | Annual General Meeting |
| 2023-05-24 09:00 am | Investor Meeting |
| 2022-11-17 07:00 am | Investor Meeting |
| 2022-09-28 02:00 am | Interim 2022 Earnings Release |
| 2022-08-24 02:00 am | Interim 2022 Sales and Revenue Release - Trading Update |
| 2022-07-26 07:00 am | Annual General Meeting |
| 2022-06-28 02:00 am | FY 2021 Earnings Release |
| 2022-02-28 02:00 am | FY 2021 Sales and Revenue Release - Trading Update |
| 2021-09-30 02:00 am | Interim 2021 Earnings Release |
| 2021-09-09 09:00 am | Investor Meeting |
| 2021-08-05 02:00 am | Interim 2021 Sales and Revenue Release - Trading Update |
| 2021-07-09 05:30 am | Annual General Meeting |
| 2021-06-17 02:00 am | FY 2020 Earnings Release |
| 2021-03-02 09:00 am | Investor Meeting |
| 2020-09-24 02:00 am | Interim 2020 Earnings Release |
| 2014-08-04 | Reverse Split: 1 of 200 |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,51 | 0,00 | 1,52 1,51 0.68% | 2,21 2,22 -0.23% |
|
EBITDA Million GBP | Released Forecast Spread | 0,00 | 0,00 | -0,74 -0,72 -2.4% | -1,02 -0,92 -10.74% |
|
EBIT Million GBP | Released Forecast Spread | 0,00 | 0,00 | -1,11 5,78 -119.22% | -1,37 -1,40 2.34% |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 0,00 | 0,00 | 5,71 5,79 -1.29% | 6,18 6,20 -0.3% |
|
Net income Million GBP | Released Forecast Spread | 0,00 | -2,12 | 5,80 5,84 -0.57% | 6,26 6,25 0.26% |
|
EPS GBP | Released Forecast Spread | -0,02 | -0,02 | 0,06 0,07 -9.4% | 0,07 0,07 -7.75% |
| Announcement Date | 29/04/19 | 28/05/20 | 17/06/21 | 28/06/22 |
Quarterly results
| Fiscal Period | December | 2019 S1 |
|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,15 |
|
EPS GBP | Released Forecast Spread | -0,01 |
| Announcement Date | 28/08/19 |
| Today 04:05 pm | EXELIXIS, INC.: Q1 2024 Earnings Release |
| 2024-04-30 | SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release |
| 2024-04-30 | MACROGENICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | REGENXBIO INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 07:00 am | NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-01 04:05 pm | SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | GERON CORPORATION: Q1 2024 Earnings Release |
Past sector events for DUCAT VENTURES
- Stock Market
- Equities
- OPTI Stock
- Stock
- Calendar DUCAT VENTURES
